Operating Lease, Right-of-Use Asset in USD of Tenaya Therapeutics, Inc. from Q2 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Tenaya Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q2 2021 to Q3 2025.
  • Tenaya Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $10.1M, a 20.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Tenaya Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $10.1M -$2.57M -20.3% 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 $10.7M -$2.97M -21.8% 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 $11.3M +$2.12M +23.1% 31 Mar 2025 10-Q 07 May 2025
Q4 2024 $11.9M +$1.91M +19.2% 31 Dec 2024 10-Q 10 Nov 2025
Q3 2024 $12.6M +$3.29M +35.2% 30 Sep 2024 10-Q 06 Nov 2024
Q2 2024 $13.7M +$3.52M +34.8% 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $9.18M -$1.73M -15.9% 31 Mar 2024 10-Q 14 May 2024
Q4 2023 $9.98M -$1.68M -14.4% 31 Dec 2023 10-K 10 Mar 2025
Q3 2023 $9.34M -$3.06M -24.7% 30 Sep 2023 10-Q 08 Nov 2023
Q2 2023 $10.1M -$2.98M -22.7% 30 Jun 2023 10-Q 09 Aug 2023
Q1 2023 $10.9M -$444K -3.91% 31 Mar 2023 10-Q 10 May 2023
Q4 2022 $11.7M -$22K -0.19% 31 Dec 2022 10-K 18 Mar 2024
Q3 2022 $12.4M +$393K +3.27% 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 $13.1M +$799K +6.49% 30 Jun 2022 10-Q 10 Aug 2022
Q1 2022 $11.4M 31 Mar 2022 10-Q 11 May 2022
Q4 2021 $11.7M 31 Dec 2021 10-K 08 Mar 2023
Q3 2021 $12M 30 Sep 2021 10-Q 10 Nov 2021
Q2 2021 $12.3M 30 Jun 2021 10-Q 08 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.